StemSmart™ MSC – Crohn's Disease
Refractory Crohn's Disease
Phase 2Active
Key Facts
Indication
Refractory Crohn's Disease
Phase
Phase 2
Status
Active
About Neuroscientific Biopharmaceuticals
Australian MSC biotech advancing StemSmart™ therapy for Crohn’s disease and other inflammatory disorders.
View full company profile